Bluejay Diagnostics (BJDX) Change in Accured Expenses (2021 - 2026)
Bluejay Diagnostics recorded quarterly Change in Accured Expenses of $268478.0 in Q1 2026, up 354.27% quarter-over-quarter from -$105588.0 in Q4 2025, and up 143.43% year-over-year from $110290.0 in Q1 2025.
Bluejay Diagnostics' Change in Accured Expenses history runs 6 years deep, the most recent figure standing at $268478.0 for Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 143.43% year-over-year to $268478.0; the TTM figure through Mar 2026 stood at $309106.0 (up 157.23% YoY), while the FY2025 annual figure was $150918.0, up 121.69% from the prior year.
- Change in Accured Expenses came in at $268478.0 for Q1 2026 at Bluejay Diagnostics, up from -$105588.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $487141.0 in Q2 2023 to a low of -$967215.0 in Q4 2023.
- A 5-year average of $1769.6 and a median of $105223.0 in 2022 frame the typical range for Change in Accured Expenses.
- Across the five-year window, Change in Accured Expenses soared 1213.97% in 2022 and tumbled 752.48% in 2023, its largest moves.
- Bluejay Diagnostics' Change in Accured Expenses stood at -$113459.0 in 2022, then plunged by 752.48% to -$967215.0 in 2023, then jumped by 90.84% to -$88561.0 in 2024, then decreased by 19.23% to -$105588.0 in 2025, then surged by 354.27% to $268478.0 in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered $268478.0, -$105588.0, and $33119.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 74.30 Mn |
| 10 | Bluejay Diagnostics | 572,394.44 | -3.11 Mn | - | 268,478.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 268,478.00 |
| Mar 31, 2026 | 268,478.00 |
| Dec 31, 2025 | -105,588.00 |
| Dec 31, 2025 | -105,588.00 |
| Sep 30, 2025 | 33,119.00 |
| Sep 30, 2025 | 33,119.00 |
| Jun 30, 2025 | 113,097.00 |
| Jun 30, 2025 | 113,097.00 |
| Mar 31, 2025 | 110,290.00 |
| Mar 31, 2025 | 110,290.00 |
| Dec 31, 2024 | -88,561.00 |
| Dec 31, 2024 | -88,561.00 |
| Sep 30, 2024 | -707,367.00 |
| Sep 30, 2024 | -707,367.00 |
| Jun 30, 2024 | 145,544.00 |
| Jun 30, 2024 | 145,544.00 |
| Mar 31, 2024 | -45,269.00 |
| Mar 31, 2024 | -45,269.00 |
| Dec 31, 2023 | -967,215.00 |
| Dec 31, 2023 | -967,215.00 |
| Sep 30, 2023 | 463,956.00 |
| Sep 30, 2023 | 463,956.00 |
| Jun 30, 2023 | 487,141.00 |
| Jun 30, 2023 | 487,141.00 |
| Mar 31, 2023 | -14,161.00 |
| Mar 31, 2023 | -14,161.00 |
| Dec 31, 2022 | -113,459.00 |
| Dec 31, 2022 | -113,459.00 |
| Sep 30, 2022 | 207,142.00 |
| Sep 30, 2022 | 207,142.00 |
| Jun 30, 2022 | 137,714.00 |
| Jun 30, 2022 | 137,714.00 |
| Mar 31, 2022 | 105,223.00 |
| Mar 31, 2022 | 105,223.00 |
| Dec 31, 2021 | -76,330.00 |
| Dec 31, 2021 | -76,330.00 |
| Sep 30, 2021 | 204,283.00 |
| Sep 30, 2021 | 204,283.00 |
| Jun 30, 2021 | 68,878.00 |
| Jun 30, 2021 | 68,878.00 |
| Mar 31, 2021 | 8,008.00 |
| Mar 31, 2021 | 8,008.00 |